What is the price-to-earnings ratio of Neurones?
The price-earnings ratio of Neurones is currently 1.42.
Neurones P/S 2024
Neurones P/S
1.42
Ticker
NRO.PA
ISIN
FR0004050250
WKN
938282
As of Jun 21, 2024, Neurones's P/S ratio stood at 1.42, a 8.4% change from the 1.31 P/S ratio recorded in the previous year.
The Neurones P/S history
Neurones Aktienanalyse
What does Neurones do?
Neurones SA is a French company specializing in IT services and consulting. It was founded in 1989 and is based in Paris. With over 10,000 employees worldwide, the company operates in over 20 countries and serves clients in various industries such as healthcare, finance, telecommunications, and the public sector. Neurones SA's business model is based on developing and implementing IT projects and providing consulting and support services tailored to its clients' specific needs. The company's divisions include management consulting, system integration, maintenance, and technology services. Its product portfolio includes solutions in CRM, ERP, CMS, as well as cloud computing, cybersecurity, and data analytics. Neurones SA's key products are the Neurones AI Suite, which utilizes AI and machine learning to automate business processes and improve decision-making, and the Smart Health Platform, a cloud-based platform for the healthcare industry. The company's clients include Air France, L'Oréal, PSA Peugeot Citroën, and Orange. Neurones SA emphasizes customer loyalty, with over 80% of its clients being long-term customers. Overall, Neurones SA is a leading IT company that specializes in providing tailored IT solutions and consulting services, and it is well-positioned for future success with its global presence and diverse range of products and services. Neurones ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Neurones's P/S Ratio
Neurones's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Neurones's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Neurones's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Neurones’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Neurones Stock
How has the price-earnings ratio of Neurones changed compared to last year?
The price-to-earnings ratio of Neurones has increased by 8.4% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Neurones high compared to other companies?
Yes, the price-to-earnings ratio of Neurones is high compared to other companies.
How does an increase in the price-earnings ratio of Neurones affect the company?
An increase in the price-earnings ratio of Neurones would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Neurones affect the company?
A decrease in the price-earnings ratio of Neurones would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Neurones?
Some factors that influence the price-earnings ratio of Neurones are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Neurones pay?
Over the past 12 months, Neurones paid a dividend of 1.1 EUR . This corresponds to a dividend yield of about 2.56 %. For the coming 12 months, Neurones is expected to pay a dividend of 1.15 EUR.
What is the dividend yield of Neurones?
The current dividend yield of Neurones is 2.56 %.
When does Neurones pay dividends?
Neurones pays a quarterly dividend. This is distributed in the months of July, July, July, July.
How secure is the dividend of Neurones?
Neurones paid dividends every year for the past 22 years.
What is the dividend of Neurones?
For the upcoming 12 months, dividends amounting to 1.15 EUR are expected. This corresponds to a dividend yield of 2.67 %.
In which sector is Neurones located?
Neurones is assigned to the 'Information technology' sector.
Wann musste ich die Aktien von Neurones kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Neurones from 6/14/2024 amounting to 1.2 EUR, you needed to have the stock in your portfolio before the ex-date on 6/12/2024.
When did Neurones pay the last dividend?
The last dividend was paid out on 6/14/2024.
What was the dividend of Neurones in the year 2023?
In the year 2023, Neurones distributed 1 EUR as dividends.
In which currency does Neurones pay out the dividend?
The dividends of Neurones are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Neurones
Our stock analysis for Neurones Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Neurones Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
